Last reviewed · How we verify

NCT05743088

COVID-19 Pandemic: Perception, Attitude

Completed Last updated 24 February 2023
What this trial tests

trial testing questionnaire in COVID-19 Pandemic in 1,990 participants. Completed in 30 July 2021.

Timeline
1 March 2021
Primary endpoint
30 July 2021
30 July 2021

Quick facts

Lead sponsorAssiut University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,990
Start date1 March 2021
Primary completion30 July 2021
Estimated completion30 July 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with COVID-19 Pandemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

: adherence to preventive control measures is influenced by perception, attitudes and practices toward the disease prevention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of questionnaire

Trials testing the same drug.

Other recruiting trials for COVID-19 Pandemic

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05743088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing